McDonnell Michael R.

McDonnell Michael R. serves as a Director at Moderna, Inc., where he is involved in strategic decision-making within the biotechnology sector. His recent disclosures, tracked through SEC Form 4 filings, highlight a focus on sale activities across multiple healthcare-related companies, including Biogen Inc. and Merit Medical Systems, Inc. Between February 10, 2025, and July 10, 2026, he reported 15 disclosures, primarily involving sales, with amounts ranging from $165.0K to $547.2K, including a notable transaction of $547,227 related to Moderna on July 10, 2026.